2021-2027 Global and Regional Antibody Drug Conjugate Industry Status and Prospects Professional Market Research Report Standard Version
Date: Aug-2021 | Id: MACRC-71720 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Antibody Drug Conjugate market was valued at 1661.27 Million USD in 2020 and will grow with a CAGR of 7.43% from 2020 to 2027, based on HNY Research newly published report. <br>The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). <br> <br>By Market Verdors: <br>Seattle Genetics/Takeda <br>Roche <br>ImmunoGen <br>Immunomedics <br>Pfizer <br>Celldex Therapeutics <br>Millennium Pharmaceuticals <br>Bayer HealthCare <br>Mersana Therapeutics <br>Heidelberg Pharma <br>Oxford BioTherapeutics <br>Takeda Pharmaceutical Company Limited <br> <br>By Types: <br>Adcetris <br>Kadcyl <br> <br>By Applications: <br>Hospital <br>Pharmaceutical Company <br>Research Institutions <br> <br>Key Indicators Analysed <br>Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. <br>Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. <br>Market Trends: Market key trends which include Increased Competition and Continuous Innovations. <br>Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology <br>Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. <br> <br>Key Reasons to Purchase <br>To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. <br>Assess the production processes, major issues, and solutions to mitigate the development risk. <br>To understand the most affecting driving and restraining forces in the market and its impact in the global market. <br>Learn about the market strategies that are being adopted by leading respective organizations. <br>To understand the future outlook and prospects for the market. <br>Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Antibody Drug Conjugate Market Size Analysis from 2022 to 2027
1.5.1 Global Antibody Drug Conjugate Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Antibody Drug Conjugate Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Antibody Drug Conjugate Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Antibody Drug Conjugate Industry Impact
Chapter 2 Global Antibody Drug Conjugate Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antibody Drug Conjugate (Volume and Value) by Type
2.1.1 Global Antibody Drug Conjugate Consumption and Market Share by Type (2016-2021)
2.1.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2016-2021)
2.2 Global Antibody Drug Conjugate (Volume and Value) by Application
2.2.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2016-2021)
2.2.2 Global Antibody Drug Conjugate Revenue and Market Share by Application (2016-2021)
2.3 Global Antibody Drug Conjugate (Volume and Value) by Regions
2.3.1 Global Antibody Drug Conjugate Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Antibody Drug Conjugate Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Antibody Drug Conjugate Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Antibody Drug Conjugate Consumption by Regions (2016-2021)
4.2 North America Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
4.10 South America Antibody Drug Conjugate Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Antibody Drug Conjugate Market Analysis
5.1 North America Antibody Drug Conjugate Consumption and Value Analysis
5.1.1 North America Antibody Drug Conjugate Market Under COVID-19
5.2 North America Antibody Drug Conjugate Consumption Volume by Types
5.3 North America Antibody Drug Conjugate Consumption Structure by Application
5.4 North America Antibody Drug Conjugate Consumption by Top Countries
5.4.1 United States Antibody Drug Conjugate Consumption Volume from 2016 to 2021
5.4.2 Canada Antibody Drug Conjugate Consumption Volume from 2016 to 2021
5.4.3 Mexico Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 6 East Asia Antibody Drug Conjugate Market Analysis
6.1 East Asia Antibody Drug Conjugate Consumption and Value Analysis
6.1.1 East Asia Antibody Drug Conjugate Market Under COVID-19
6.2 East Asia Antibody Drug Conjugate Consumption Volume by Types
6.3 East Asia Antibody Drug Conjugate Consumption Structure by Application
6.4 East Asia Antibody Drug Conjugate Consumption by Top Countries
6.4.1 China Antibody Drug Conjugate Consumption Volume from 2016 to 2021
6.4.2 Japan Antibody Drug Conjugate Consumption Volume from 2016 to 2021
6.4.3 South Korea Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 7 Europe Antibody Drug Conjugate Market Analysis
7.1 Europe Antibody Drug Conjugate Consumption and Value Analysis
7.1.1 Europe Antibody Drug Conjugate Market Under COVID-19
7.2 Europe Antibody Drug Conjugate Consumption Volume by Types
7.3 Europe Antibody Drug Conjugate Consumption Structure by Application
7.4 Europe Antibody Drug Conjugate Consumption by Top Countries
7.4.1 Germany Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.2 UK Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.3 France Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.4 Italy Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.5 Russia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.6 Spain Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.7 Netherlands Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.8 Switzerland Antibody Drug Conjugate Consumption Volume from 2016 to 2021
7.4.9 Poland Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 8 South Asia Antibody Drug Conjugate Market Analysis
8.1 South Asia Antibody Drug Conjugate Consumption and Value Analysis
8.1.1 South Asia Antibody Drug Conjugate Market Under COVID-19
8.2 South Asia Antibody Drug Conjugate Consumption Volume by Types
8.3 South Asia Antibody Drug Conjugate Consumption Structure by Application
8.4 South Asia Antibody Drug Conjugate Consumption by Top Countries
8.4.1 India Antibody Drug Conjugate Consumption Volume from 2016 to 2021
8.4.2 Pakistan Antibody Drug Conjugate Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Antibody Drug Conjugate Market Analysis
9.1 Southeast Asia Antibody Drug Conjugate Consumption and Value Analysis
9.1.1 Southeast Asia Antibody Drug Conjugate Market Under COVID-19
9.2 Southeast Asia Antibody Drug Conjugate Consumption Volume by Types
9.3 Southeast Asia Antibody Drug Conjugate Consumption Structure by Application
9.4 Southeast Asia Antibody Drug Conjugate Consumption by Top Countries
9.4.1 Indonesia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.2 Thailand Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.3 Singapore Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.4 Malaysia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.5 Philippines Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.6 Vietnam Antibody Drug Conjugate Consumption Volume from 2016 to 2021
9.4.7 Myanmar Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 10 Middle East Antibody Drug Conjugate Market Analysis
10.1 Middle East Antibody Drug Conjugate Consumption and Value Analysis
10.1.1 Middle East Antibody Drug Conjugate Market Under COVID-19
10.2 Middle East Antibody Drug Conjugate Consumption Volume by Types
10.3 Middle East Antibody Drug Conjugate Consumption Structure by Application
10.4 Middle East Antibody Drug Conjugate Consumption by Top Countries
10.4.1 Turkey Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.3 Iran Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.5 Israel Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.6 Iraq Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.7 Qatar Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.8 Kuwait Antibody Drug Conjugate Consumption Volume from 2016 to 2021
10.4.9 Oman Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 11 Africa Antibody Drug Conjugate Market Analysis
11.1 Africa Antibody Drug Conjugate Consumption and Value Analysis
11.1.1 Africa Antibody Drug Conjugate Market Under COVID-19
11.2 Africa Antibody Drug Conjugate Consumption Volume by Types
11.3 Africa Antibody Drug Conjugate Consumption Structure by Application
11.4 Africa Antibody Drug Conjugate Consumption by Top Countries
11.4.1 Nigeria Antibody Drug Conjugate Consumption Volume from 2016 to 2021
11.4.2 South Africa Antibody Drug Conjugate Consumption Volume from 2016 to 2021
11.4.3 Egypt Antibody Drug Conjugate Consumption Volume from 2016 to 2021
11.4.4 Algeria Antibody Drug Conjugate Consumption Volume from 2016 to 2021
11.4.5 Morocco Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 12 Oceania Antibody Drug Conjugate Market Analysis
12.1 Oceania Antibody Drug Conjugate Consumption and Value Analysis
12.2 Oceania Antibody Drug Conjugate Consumption Volume by Types
12.3 Oceania Antibody Drug Conjugate Consumption Structure by Application
12.4 Oceania Antibody Drug Conjugate Consumption by Top Countries
12.4.1 Australia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
12.4.2 New Zealand Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 13 South America Antibody Drug Conjugate Market Analysis
13.1 South America Antibody Drug Conjugate Consumption and Value Analysis
13.1.1 South America Antibody Drug Conjugate Market Under COVID-19
13.2 South America Antibody Drug Conjugate Consumption Volume by Types
13.3 South America Antibody Drug Conjugate Consumption Structure by Application
13.4 South America Antibody Drug Conjugate Consumption Volume by Major Countries
13.4.1 Brazil Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.2 Argentina Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.3 Columbia Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.4 Chile Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.5 Venezuela Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.6 Peru Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Antibody Drug Conjugate Consumption Volume from 2016 to 2021
13.4.8 Ecuador Antibody Drug Conjugate Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Antibody Drug Conjugate Business
14.1 Seattle Genetics/Takeda
14.1.1 Seattle Genetics/Takeda Company Profile
14.1.2 Seattle Genetics/Takeda Antibody Drug Conjugate Product Specification
14.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Roche
14.2.1 Roche Company Profile
14.2.2 Roche Antibody Drug Conjugate Product Specification
14.2.3 Roche Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 ImmunoGen
14.3.1 ImmunoGen Company Profile
14.3.2 ImmunoGen Antibody Drug Conjugate Product Specification
14.3.3 ImmunoGen Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Immunomedics
14.4.1 Immunomedics Company Profile
14.4.2 Immunomedics Antibody Drug Conjugate Product Specification
14.4.3 Immunomedics Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Pfizer
14.5.1 Pfizer Company Profile
14.5.2 Pfizer Antibody Drug Conjugate Product Specification
14.5.3 Pfizer Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Celldex Therapeutics
14.6.1 Celldex Therapeutics Company Profile
14.6.2 Celldex Therapeutics Antibody Drug Conjugate Product Specification
14.6.3 Celldex Therapeutics Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Millennium Pharmaceuticals
14.7.1 Millennium Pharmaceuticals Company Profile
14.7.2 Millennium Pharmaceuticals Antibody Drug Conjugate Product Specification
14.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bayer HealthCare
14.8.1 Bayer HealthCare Company Profile
14.8.2 Bayer HealthCare Antibody Drug Conjugate Product Specification
14.8.3 Bayer HealthCare Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Mersana Therapeutics
14.9.1 Mersana Therapeutics Company Profile
14.9.2 Mersana Therapeutics Antibody Drug Conjugate Product Specification
14.9.3 Mersana Therapeutics Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Heidelberg Pharma
14.10.1 Heidelberg Pharma Company Profile
14.10.2 Heidelberg Pharma Antibody Drug Conjugate Product Specification
14.10.3 Heidelberg Pharma Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Oxford BioTherapeutics
14.11.1 Oxford BioTherapeutics Company Profile
14.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Product Specification
14.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Takeda Pharmaceutical Company Limited
14.12.1 Takeda Pharmaceutical Company Limited Company Profile
14.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Specification
14.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Antibody Drug Conjugate Market Forecast (2022-2027)
15.1 Global Antibody Drug Conjugate Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Antibody Drug Conjugate Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Antibody Drug Conjugate Value and Growth Rate Forecast (2022-2027)
15.2 Global Antibody Drug Conjugate Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Antibody Drug Conjugate Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Antibody Drug Conjugate Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Antibody Drug Conjugate Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Antibody Drug Conjugate Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Antibody Drug Conjugate Consumption Forecast by Type (2022-2027)
15.3.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2022-2027)
15.3.3 Global Antibody Drug Conjugate Price Forecast by Type (2022-2027)
15.4 Global Antibody Drug Conjugate Consumption Volume Forecast by Application (2022-2027)
15.5 Antibody Drug Conjugate Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000